People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping GLP-1 injections, a new trial shows.
A global study reveals an alarming rise in gout cases among young people aged 15 to 39, with rates increasing 66% from 1990 ...
The debate over whether insurers should pay for GLP-1 drugs like Ozempic and Wegovy has revived a familiar American argument ...
A new AP-NORC poll finds that Americans are more likely to prioritize health care than they were last year, while immigration and rising costs remain pressing issues. (AP Video: Nathan Ellgren) ...